Skip to content

Clinical trials

Phase 2/3 Respiratory Tract Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Tract Diseases Phase: Phase 2/3 Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20091
20102
20111
20152
20181
20201
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting1
Terminated1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Aeris Therapeutics2
Alpha Biopharma (Jiangsu) Co., Ltd.1
Assistance Publique - Hôpitaux de Paris1
Barts & The London NHS Trust1
Daniels, Craig E., M.D.1
Guangzhou JOYO Pharma Co., Ltd1
Hospital de Clinicas de Porto Alegre1
Laboratorios Roemmers S.A.I.C.F.1
Thirty Respiratory Limited1
University of Washington, the Collaborative Health Studies Coordinating Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Tract Diseases11
Lung Diseases5
Pathologic Processes3
Digestive System Diseases2
Emphysema2
Idiopathic Pulmonary Fibrosis2
Pulmonary Disease, Chronic Obstructive2
Pulmonary Emphysema2
Pulmonary Fibrosis2
Respiratory Aspiration2

Trials

Showing 76 to 11 of 11. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.